Accurna

Provider of nucleic acid therapeutics using drug delivery platform

placeBunkyo, Tokyo, Japan calendar_todayFounded 2015 groups23 employees language accurna.com

Innovation

3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 105 times.

YearFilings
20161
20172
20182
20192

Investor mix

4 investors on record; lead investors include Fast Track Initiative, UTokyo Innovation Platform, SMBC Venture Capital, NanoCarrier.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon